Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurology

R J Joynt1

  • 1University of Rochester, NY, USA.

JAMA
|June 7, 1995
PubMed
Summary

Carotid endarterectomy benefits patients with significant asymptomatic carotid stenosis. Left ventricular mass is a newly identified stroke risk factor, alongside existing conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Crisis in the Presidency. The physician's role in assessing official capacity.

Neurology·1997
Same author

Neurology.

JAMA·1997
Same author

Neurogenetics and primary care.

Neurology·1997
Same author

The neurologist and managed care.

Archives of neurology·1996
Same author

Neurology.

JAMA·1996
Same author

The cost of strokes: Two views.

Neurology·1996

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Vascular Surgery

Background:

  • Asymptomatic carotid stenosis exceeding 60% diameter reduction is a clinical concern.
  • The Framingham Heart Study has provided significant insights into cardiovascular risk factors.
  • Identifying novel stroke risk factors is crucial for preventative strategies.

Purpose of the Study:

  • To evaluate the efficacy of carotid endarterectomy for asymptomatic carotid stenosis.
  • To investigate the association between left ventricular mass and stroke risk.
  • To review the therapeutic landscape for multiple sclerosis.

Main Methods:

  • Analysis of outcomes for patients undergoing carotid endarterectomy.
  • Utilizing data from the Framingham Heart Study to assess risk factors.
  • Reviewing clinical trial data for Betaseron in multiple sclerosis treatment.

Main Results:

  • Carotid endarterectomy demonstrates benefit in patients with >60% asymptomatic carotid stenosis.
  • Left ventricular mass was identified as an independent risk factor for stroke.
  • Betaseron is an approved treatment for specific multiple sclerosis patient cohorts.

Conclusions:

  • Carotid endarterectomy is a recommended intervention for severe asymptomatic carotid stenosis.
  • Left ventricular mass should be considered in stroke risk assessments.
  • Betaseron offers a treatment option for eligible multiple sclerosis patients.

Related Experiment Videos